Shigekazu Iguchi
Juntendo University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Shigekazu Iguchi.
Histopathology | 2010
Hajime Yasuda; Jun Ando; Toshiharu Matsumoto; Kanako Ogura; Yutaka Ozaki; Nanae Aritaka; Yuji Aoki; Manabu Sugita; Tomohisa Nomura; Hajime Sekii; Naotaka Yamaguchi; Shigekazu Iguchi; Takahiro Yamamoto; Norio Komatsu; Takao Hirano
1. Mutter GL, Baak JPA, Crum CP, Richart RM, Ferenczy A, Farquir W. Endometrial precancer diagnosis by histopathology, clonal analysis and computerized morphometry. J. Pathol. 2000; 190; 462–469. 2. Mutter GL, The Endometrial Collaborative Group. Endometrial intraepithelial neoplasia (EIN): will it bring order of chaos? Gynecol. Oncol. 2000; 76; 287–290. 3. Mutter GL. Diagnosis of premalignant endometrial disease. J. Clin. Pathol. 2002; 55; 326–331. 4. Baak JP, Mutter GL. EIN and WHO 94. J. Clin. Pathol. 2005; 58; 1– 6. 5. Mutter GL. PTEN: a protean tumor suppressor. Am. J. Pathol. 2001; 158; 1895–1898. 6. Dunton C, Baak J, Van Diest P, McHugh M, Widra E. Use of computerized morphometric analysis of endometrial hyperplasia in the prediction of coexistent cancer. Am. J. Obstet. Gynecol. 1996; 174; 1518–1521.
PLOS ONE | 2016
Shigekazu Iguchi; Tomonori Mizutani; Keiichi Hiramatsu; Ken Kikuchi
Background We previously reported the case of a 64-year-old man with mediastinitis caused by Staphylococcus aureus in which the infecting bacterium acquired linezolid resistance after only 14 days treatment with linezolid. We therefore investigated relevant clinical isolates for possible mechanisms of this rapid acquisition of linezolid resistance. Methods Using clinical S. aureus isolates, we assessed the in vitro mutation rate and performed stepwise selection for linezolid resistance. To investigate homologous recombination, sequences were determined for each of the 23S ribosomal RNA (23S rRNA) loci; analyzed sequences spanned the entirety of each 23S rRNA gene, including domain V, as well as the 16S-23S intergenic spacer regions. We additionally performed next-generation sequencing on clinical strains to identify single-nucleotide polymorphisms compared to the N315 genome. Results Strains isolated from the patient prior to linezolid exposure (M5-M7) showed higher-level linezolid resistance than N315, and the pre-exposure strain (M2) exhibited more rapid acquisition of linezolid resistance than did N315. However, the mutation rates of these and contemporaneous clinical isolates were similar to those of N315, and the isolates did not exhibit any mutations in hypermutation-related genes. Sequences of the 23S rRNA genes and 16S-23S intergenic spacer regions were identical among the pre- and post-exposure clinical strains. Notably, all of the pre-exposure isolates harbored a recQ missense mutation (Glu69Asp) with respect to N315; such a lesion may have affected short sequence recombination (facilitating, for example, recombination among rrn loci). We hypothesize that this mechanism contributed to rapid acquisition of linezolid resistance. Conclusions Hypermutation and homologous recombination of the ribosomal RNA genes, including 23S rRNA genes, appear not to have been sources of the accelerated acquisition of linezolid resistance observed in our clinical case. Increased frequency of short sequence recombination may have resulted from a recQ variant in the infecting organism.
International Journal of Systematic and Evolutionary Microbiology | 2017
Mari Tohya; Sakura Arai; Junko Tomida; Takayasu Watanabe; Yoshiaki Kawamura; Masanori Katsumi; Mariko Ushimizu; Kasumi Ishida-Kuroki; Mina Yoshizumi; Yutaka Uzawa; Shigekazu Iguchi; Atsushi Yoshida; Ken Kikuchi; Tsutomu Sekizaki
To clarify the taxonomic classification of Streptococcus suis serotype 33, we performed biochemical and molecular genetic analyses using isolates (GUT-183, GUT-184, GUT-185, GUT-186, GUT-187T, GUT-188, GUT-189, GUT-190, GUT-191, GUT-192 and GUT-193) from bovine endocarditis. A comparative sequence analysis showed 99.2-100 % sequence similarity among the reference strain of S. suis serotype 33 and our isolates for the 16S rRNA gene. These similarities were higher than those between the isolate GUT-187T and S. suis and other streptococci. Comparison of sodA genes also showed high degrees of similarities among the reference strain of S. suis serotype 33 and our isolates (99.7-100 %), which were higher than those between the GUT-187T and S. suis and other streptococci. DNA-DNA relatedness among three isolates (GUT-186, GUT-187T, the reference strain of S. suis serotype 33) was over 76.7 %. In contrast, the relatedness between GUT-187T and the other streptococcal species (S. suis, Streptococcus parasuis, Streptococcus acidominimus and Streptococcus porci) was 8.4-24.9 %. Phylogenetic analyses showed that the isolates did not affiliate closely to any known species of the genus Streptococcus. Moreover, GUT-187T could be distinguished from S. suis and other closely related species of genus Streptococcus using biochemical tests. On the basis of the phenotypic and molecular genetic data, we propose that the isolates of S. suis serotype 33 should be classified into the genus Streptococcus, Streptococcus ruminantium sp. nov. with the type strain GUT-187T (=DSM 104980T=JCM 31869T).
Canadian Journal of Infectious Diseases & Medical Microbiology | 2017
Ken Kikuchi; Mari Matsuda; Shigekazu Iguchi; Tomonori Mizutani; Keiichi Hiramatsu; Michiru Tega-Ishii; Kaori Sansaka; Kenta Negishi; Kimie Shimada; Jun Umemura; Shigeyuki Notake; Hideji Yanagisawa; Hiroshi Takahashi; Reiko Yabusaki; Hideki Araoka; Akiko Yoneyama
Background. Early detection of Gram-positive bacteremia and timely appropriate antimicrobial therapy are required for decreasing patient mortality. The purpose of our study was to evaluate the performance of the Verigene Gram-positive blood culture assay (BC-GP) in two special healthcare settings and determine the potential impact of rapid blood culture testing for Gram-positive bacteremia within the Japanese healthcare delivery system. Furthermore, the study included simulated blood cultures, which included a library of well-characterized methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) isolates reflecting different geographical regions in Japan. Methods. A total 347 BC-GP assays were performed on clinical and simulated blood cultures. BC-GP results were compared to results obtained by reference methods for genus/species identification and detection of resistance genes using molecular and MALDI-TOF MS methodologies. Results. For identification and detection of resistance genes at two clinical sites and simulated blood cultures, overall concordance of BC-GP with reference methods was 327/347 (94%). The time for identification and antimicrobial resistance detection by BC-GP was significantly shorter compared to routine testing especially at the cardiology hospital, which does not offer clinical microbiology services on weekends and holidays. Conclusion. BC-GP generated accurate identification and detection of resistance markers compared with routine laboratory methods for Gram-positive organisms in specialized clinical settings providing more rapid results than current routine testing.
Medical mycology case reports | 2018
Utako Okata-Karigane; Yasuki Hata; Emiko Watanabe-Okada; Shunichi Miyakawa; Michi Ota; Yutaka Uzawa; Shigekazu Iguchi; Atsushi Yoshida; Ken Kikuchi
A 60-year-old Japanese man presented with multiple subcutaneous nodules in his left groin. Histologically, the nodules consisted of suppurative granulomas and abscesses not involving the hair follicles. Trichophyton rubrum TWCC57922 was detected by fungal culture and polymerase chain reaction (PCR) sequencing of the rDNA genes. We diagnosed these nodules as deeper dermal dermatophytosis, a rare form of invasive dermatophytosis. He was treated with terbinafine. We compared these findings with previous reports of deep dermal dermatophytosis.
BMC Infectious Diseases | 2018
Toshinobu Yamagishi; Mayu Hikone; Kazuhiro Sugiyama; Takahiro Tanabe; Yasuhiro Wada; Michiko Furugaito; Yuko Arai; Yutaka Uzawa; Ryo Mizushima; Keisuke Kamada; Yasutomo Itakura; Shigekazu Iguchi; Atsushi Yoshida; Ken Kikuchi; Yuichi Hamabe
BackgroundGemella bergeri is one of the nine species of the genus Gemella and is relatively difficult to identify. We herein describe the first case of septic shock due to a Gemella bergeri coinfection with Eikenella corrodens.Case presentationA 44-year-old Asian man with a medical history of IgG4-related ophthalmic disease who was prescribed corticosteroids (prednisolone) presented to our hospital with dyspnea. On arrival, he was in shock, and a purpuric eruption was noted on both legs. Contrast enhanced computed tomography showed fluid retention at the right maxillary sinus, left lung ground glass opacity, and bilateral lung irregular opacities without cavitation. Owing to suspected septic shock, fluid resuscitation and a high dose of vasopressors were started. In addition, meropenem, clindamycin, and vancomycin were administered. Repeat computed tomography confirmed left internal jugular and vertebral vein thrombosis. Following this, the patient was diagnosed with Lemierre’s syndrome. Furthermore, he went into shock again on day 6 of hospitalization. Additional soft tissue infections were suspected; therefore, bilateral below the knee amputations were performed for source control. Cultures of the exudates from skin lesions and histopathological samples did not identify any pathogens, and histopathological findings showed arterial thrombosis; therefore it was concluded that the second time shock was associated with purpura fulminans. Following this, his general status improved. He was transferred to another hospital for rehabilitation. The blood culture isolates were identified as Gemella bergeri and Eikenella corrodens. Gemella bergeri was identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry and confirmed by 16S rRNA gene sequencing later. The primary focus of the infection was thought to be in the right maxillary sinus, because the resolution of the fluid retention was confirmed by repeat computed tomography.ConclusionsGemella bergeri can be the causative pathogen of septic shock. If this pathogen cannot be identified manually or through commercial phenotypic methods, 16S rRNA gene sequencing should be considered.
Medicine | 2017
Shigekazu Iguchi; Naotaka Yamaguchi; Hiroki Takami; Takayuki Komatsu; Hirokazu Ookubo; Hajime Sekii; Kenji Inoue; Shinya Okazaki; Iwao Okai; Sonomi Maruyama; Tomohisa Nomura; Manabu Sugita
Rationale: Cases of severe disopyramide poisoning are rare and few have been reported. We report a case in which activated-charcoal column hemoperfusion was dramatically effective for life-threatening disopyramide poisoning. Patient concerns: A teenage girl who had overdosed on disopyramide (total dose, 4950 mg) was brought to our hospital. She was resuscitated from short period cardiopulmonary arrest and subsequently showed severe cardiogenic shock and ventricular arrhythmia. Diagnoses: Disopyramide poisoning (self-evident). Interventions: As hemodynamics remained unstable after providing percutaneous cardiopulmonary support and intra-aortic balloon pumping, we attempted direct hemoperfusion using a coated activated-charcoal hemoperfusion column. Outcomes: Hemodynamics including electrocardiography and serum disopyramide concentration were dramatically improved, and the patient was ambulatory by hospital day 14. Lessons: Because disopyramide has low molecular weight and a small distribution volume, blood purification is considered to be the most effective therapy. We selected direct hemoperfusion for relatively high protein-binding rate. In fact, clinical status was dramatically improved, and the calculated half-life of the direct hemoperfusion phase was the shortest of all phases. In cases of severe or life-threatening disopyramide poisoning, blood purification therapy including direct hemoperfusion using a coated activated-charcoal column should be performed.
Japanese Journal of Infectious Diseases | 2018
Shigekazu Iguchi; Ryo Mizushima; Keisuke Kamada; Yasutomo Itakura; Atsushi Yoshida; Yutaka Uzawa; Yuko Arai; Miyako Takaoka; Sumie Sato; Aeko Goto; Toshiko Karasawa; Naoki Tsuruoka; Daisuke Totsuka; Erika Ono; Manabu Nonaka; Koichi Makimura; Ken Kikuchi
Journal of Infection and Chemotherapy | 2017
Mayu Hikone; Naoya Sakamoto; Masayuki Ota; Takuya Washino; Ken-ichiro Kobayashi; Sentaro Iwabuchi; Haruko Kazama; Akiko Kounosu; Kumiko Negishi; Yusuke Ainoda; Shigekazu Iguchi; Atsushi Yoshida; Ken Kikuchi; Kenji Ohnishi
Journal of Infection and Chemotherapy | 2018
Takuma Ohnishi; Masayoshi Shinjoh; Hirotoshi Ohara; Toshinao Kawai; Isamu Kamimaki; Ryo Mizushima; Keisuke Kamada; Yasutomo Itakura; Shigekazu Iguchi; Yutaka Uzawa; Atsushi Yoshida; Ken Kikuchi